
亚太地区气道管理设备市场预测至 2028 年 - COVID-19 影响和区域分析 - 按产品 [声门下设备(气管插管、气管切开插管等)、声门上设备、喉镜、复苏器等] 和结束用户(医院、门诊手术护理中心等)
No. of Pages: 139 | Report Code: BMIRE00027556 | Category: Life Sciences
No. of Pages: 139 | Report Code: BMIRE00027556 | Category: Life Sciences
亚太地区气道管理设备市场预计将从 2022 年的 3.9118 亿美元增长到 2028 年的 5.9749 亿美元。预计将以2022 年至 2028 年复合年增长率为 7.3%。
市场参与者之间的研发活动和合作不断增加< /strong>
医疗器械研发被认为是资本高度密集型且充满巨大风险的。研发是必不可少的一步,在此之后最好的想法会转化为最好的产品。蓬勃发展的研发生态系统可以成为开发有竞争力的顶级产品的完美土壤,从理想的产品设计构思到新产品开发、原型设计、验证和测试。为了生产创新产品,医疗科技公司正在将很大一部分收入投资于研发。该公司持续专注于新的创新产品和解决方案的开发和商业化,旨在改善患者的治疗效果,帮助医生和医疗服务提供者更好地管理慢性病,并降低医疗成本。此外,市场参与者之间还开展了多项战略合作,以共享研究、制造、设计和技术等资源,以开发新的创新产品。市场主体多以合资、合伙、兼并等方式参与。收购,这可能会促进市场增长。
市场参与者采取的一些战略举措如下:
2021 年 5 月,泰利福签订了一项最终协议,将全球呼吸产品组合中的某些产品线出售给 Medline Industries Inc.
2021 年 5 月,Medline 签署了一项最终协议,收购 Teleflex 呼吸业务业务 Hudson RCI 品牌下的精选资产。
市场概览
亚太地区气道管理设备市场分为中国、日本、印度、韩国、澳大利亚和亚太其他地区。亚太地区预计将成为增长最快的地区,其中中国占据主要市场份额;然而,预计印度在预测期内将以显着的复合年增长率发展。该地区的市场增长归因于慢性阻塞性肺病、哮喘、囊性纤维化和肺气肿等呼吸系统疾病的患病率不断上升,以及易患此类疾病的老年人口激增。此外,COVID-19大流行进一步创造了对气道管理设备的需求,以大规模管理COVID-19患者。此外,COVID-19 病例的增加导致一次性气道管理设备的需求和生产增加,以防止感染进一步传播。所有这些因素都推动了该地区气道管理设备市场的增长。
亚太地区气道管理设备市场细分
亚太地区气道管理设备市场分为产品和最终用户。< /p>
Teleflex Incorporated;史密斯医疗;美敦力;英特外科有限公司;安布公司;麦德林工业公司;皇家飞利浦公司;阿姆斯特朗医疗;和 Cook Medical LLC 是该地区气道管理设备市场的领先公司之一。
Strategic insights for Asia Pacific Airway Management Devices involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
Report Attribute | Details |
---|---|
Market size in 2022 | US$ 391.18 Million |
Market Size by 2028 | US$ 597.49 Million |
Global CAGR (2022 - 2028) | 7.3% |
Historical Data | 2020-2021 |
Forecast period | 2023-2028 |
Segments Covered |
By 产品
|
Regions and Countries Covered | 亚太地区
|
Market leaders and key company profiles |
The regional scope of Asia Pacific Airway Management Devices refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The Asia Pacific Airway Management Devices Market is valued at US$ 391.18 Million in 2022, it is projected to reach US$ 597.49 Million by 2028.
As per our report Asia Pacific Airway Management Devices Market, the market size is valued at US$ 391.18 Million in 2022, projecting it to reach US$ 597.49 Million by 2028. This translates to a CAGR of approximately 7.3% during the forecast period.
The Asia Pacific Airway Management Devices Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific Airway Management Devices Market report:
The Asia Pacific Airway Management Devices Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Asia Pacific Airway Management Devices Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Asia Pacific Airway Management Devices Market value chain can benefit from the information contained in a comprehensive market report.